Tg Therapeutics (TGTX) EBT Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly EBT Margin of 9.94% for Q1 2026, up 541.0% year-over-year from 1.55% in Q1 2025, and down 57.89% quarter-over-quarter from 23.6% in Q4 2025.
Tg Therapeutics (TGTX) EBT Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' EBT Margin history runs 10 years deep, the most recent figure standing at 9.94% for Q1 2026.
- In Q1 2026, EBT Margin rose 541.0% year-over-year to 9.94%; the TTM figure through Mar 2026 stood at 17.51% (up 648.0% YoY), while the FY2025 annual figure was 17.48%, up 944.0% from the prior year.
- EBT Margin for Q1 2026 stood at 9.94%, down from 23.6% in the prior quarter.
- The five-year high for EBT Margin was 68.71% in Q3 2023, with the low at 94568.75% in Q4 2022.
- The 5-year median for EBT Margin is 4.52% (2025), against an average of 8941.43%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 9043747 bps in 2022, then soared 9453685 bps in 2023.
- Tg Therapeutics' EBT Margin stood at 94568.75% in 2022, then surged by 100 bps to 31.9% in 2023, then soared by 176 bps to 24.34% in 2024, then slipped by 3 bps to 23.6% in 2025, then tumbled by 58 bps to 9.94% in 2026.
- Business Quant data shows TGTX's EBT Margin at 9.94% in Q1 2026, 23.6% in Q4 2025, and 16.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 4.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26% |
| Mar 31, 2026 | 9.94% |
| Dec 31, 2025 | 23.60% |
| Sep 30, 2025 | 16.02% |
| Jun 30, 2025 | 21.91% |
| Mar 31, 2025 | 4.52% |
| Dec 31, 2024 | 24.34% |
| Sep 30, 2024 | 5.09% |
| Jun 30, 2024 | 8.92% |
| Mar 31, 2024 | -16.82% |
| Dec 31, 2023 | -31.90% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -94,568.75% |
| Sep 30, 2022 | -43,577.66% |
| Jun 30, 2022 | -9,466.33% |
| Mar 31, 2022 | -3,726.84% |
| Dec 31, 2021 | -4,131.28% |
| Sep 30, 2021 | -5,082.46% |